About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares iBonds Dec 2021 Term Treasury ETF (NY:IBTA)

20.66 -0.44 (-2.09%)
Official Closing Price Updated: 7:00 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares iBonds Dec 2021 Term Treasury ETF

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Ibotta To Announce Fourth Quarter 2025 Financial Results on February 25, 2026
From Ibotta
Via Business Wire
News headline image
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Varonis Systems, Inc. (NASDAQ: VRNS): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of CoreWeave, Inc. (NASDAQ: CRWV); Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); and Varonis Systems, Inc. (NASDAQ: VRNS): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
2 Reasons to Like IBTA and 1 to Stay Skeptical
Ibotta’s stock price has taken a beating over the past six months, shedding 37.8% of its value and falling to $22.96 per share. This may have investors wondering how to approach the situation. 
Via StockStory
News headline image
2 Cash-Producing Stocks Worth Investigating and 1 We Brush Off
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Topics ETFs
News headline image
Why Ibotta (IBTA) Shares Are Sliding Today
Shares of cash-back rewards platform Ibotta (NYSE:IBTA) fell 2.4% in the afternoon session after reports revealed that Cathie Wood's ARK Invest continued to sell its stake in the company. According to... 
Via StockStory
Topics Initial Public Offering
News headline image
1 Russell 2000 Stock with Promising Prospects and 2 We Question
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 Facing Challenges
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
The Transit OS: Why Koch Is Betting on Via’s Rewrite of Public Mobility ↗
Koch bought into Via as the company pushes deeper into transit software. This article breaks down the story behind the move and the signals investors should watch from here. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and Stride, Inc. (NYSE: LRN): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Ibotta, PAR Technology, Xerox, Amentum, and Plexus Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts. 
Via StockStory
Topics Artificial Intelligence Earnings Stocks
News headline image
3 Services Stocks That Concern Us
Business services providers use their specialized expertise to help enterprises streamline operations and cut costs. Still, investors are uneasy as firms face challenges from AI-driven disruptors and... 
Via StockStory
Topics Stocks
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and Stride, Inc. (NYSE: LRN): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
5 Must-Read Analyst Questions From Ibotta’s Q3 Earnings Call
Ibotta’s third quarter was marked by a sharp revenue decline and compressed margins, which contributed to a significant negative market reaction. Management pointed to ongoing macroeconomic... 
Via StockStory
Topics Artificial Intelligence Earnings World Trade
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); enCore Energy Corp. (NASDAQ: EU); Fluor Corporation (NYSE: FLR); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating
From Grabar Law Office
Via GlobeNewswire
News headline image
Q3 Rundown: Ibotta (NYSE:IBTA) Vs Other Advertising & Marketing Services Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the advertising & marketing services industry, including Ibotta (NYSE:IBTA) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Important Notice to Long-Term Shareholders of enCore Energy Corp. (NASDAQ: EU); Fluor Corporation (NYSE: FLR); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Ibotta and ABCS Insights Announce Partnership to Advance Campaign Measurement for Digital Promotions
From Ibotta
Via Business Wire
News headline image
Ibotta to Participate in Upcoming Investor Conferences
From Ibotta, Inc.
Via Business Wire
News headline image
IBTA Q3 Deep Dive: Strategic Transformation Amid Revenue Decline and Margin Pressure
Cash-back rewards platform Ibotta (NYSE:IBTA) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales fell by 15.6% year on year to $83.26 million. On the other hand, next... 
Via StockStory
News headline image
Ibotta (IBTA) Q3 2025 Earnings Call Transcript ↗
Ibotta (IBTA) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Communication Services Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Cisco Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Ibotta’s (NYSE:IBTA) Q3 CY2025 Sales Top Estimates But Stock Drops 14%
Cash-back rewards platform Ibotta (NYSE:IBTA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 15.6% year on year to $83.26 million. On the other hand, next quarter’s... 
Via StockStory
News headline image
Ibotta Reports Third Quarter 2025 Financial Results
From Ibotta, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.